- Investing Ideas
- Swedish Pharmaceuticals & Biotech Profitable Climbers
Swedish Pharmaceuticals & Biotech Profitable Climbers
Results
6
6 companies
Camurus
Market Cap: SEK 28.0b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 468.20
7D
-2.6%
1Y
-22.7%
Bonesupport Holding
Market Cap: SEK 13.1b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 196.10
7D
-0.5%
1Y
-42.5%
Genovis AB (publ.)
Market Cap: SEK 1.1b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 16.72
7D
0.2%
1Y
-23.3%
BioGaia
Market Cap: SEK 11.5b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 113.40
7D
2.8%
1Y
-1.7%
Swedencare
Market Cap: SEK 4.0b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 24.95
7D
2.5%
1Y
-36.0%
Swedish Orphan Biovitrum
Market Cap: SEK 128.9b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 372.80
7D
-1.0%
1Y
27.7%